The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the stem cell umbilical cord blood market size. Based on the storage services, the private cord blood banks segment expected to grow at the highest XX.06% CAGR during the forecast period thanks to technological developments done at the storage services. Also, by application, regenerative medicine is expected to grow at the highest CAGR of XX.15% and is expected to reach a value of US$ XX Mn. by 2027. This is attributed to regenerative medicines in organ transplant to remove the use of immune-suppressing medicines and anti-inflammatory action that are necessary to treat artificial tissues, organ, and bone.